EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

The Physiological and Performance Effects of Actovegin during Maximal Cardiopulmonary Exercise Testing: A Randomized, Double-Blind, Placebo-Controlled Trial

Dragana Milovanović iD, Dragan Radovanović iD, Vladimir Živković, Ivan Srejović iD, Miloš Glišić, Vladimir Jakovljević iD, Aaron Scanlan iD, Nenad Ponorac, Emilija Stojanović iD

Nutrients · 2024

DOI: 10.3390/nu16193332 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Dragana Milovanović und 8 weiteren Autor:innen. Beteiligte Einrichtung: Military Medical Academy, 11000 Belgrade, Serbia. Hauptthemen laut MEDLINE: Exercise Test, Oxygen Consumption, Athletes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculty of Medical Sciences, Ministry of Science, Technological Development, and Innovation of the Republic of Serbia, L’Oréal-UNESCO “For Women in Science” Serbian national programme and Humboldt Research Fellowship Programme for Experienced Researchers.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Evidence regarding the performance-related effects of Actovegin is limited, despite legislated restrictions being in place for this supplement within sport settings.

Objectives

Our study examined the effects of Actovegin on physiological responses and performance during maximal cardiopulmonary exercise in collegiate athletes.

Methods

A randomized, double-blind, placebo-controlled experimental design was adopted. Moderately trained collegiate athletes from various sports were randomly allocated to placebo (n = 8) or Actovegin (n = 8) groups. All athletes consumed three capsules across each day for seven days of loading. Athletes underwent two separate cardiopulmonary exercise tests one week apart. Separate 2 × 2 mixed ANOVAs and effect sizes (ηp2) were used to assess for between- and within-group differences.

Results

A significant time * group effect (p = 0.036, ηp2 = 0.278) was observed in systolic blood pressure. Significant main effects were only observed for time in several variables, with increases in peak oxygen uptake (VO2) (p < 0.001, ηp2 = 0.893), peak minute ventilation (p = 0.004, ηp2 = 0.456), ventilatory equivalents for carbon dioxide (p = 0.002, ηp2 = 0.517), oxygen pulse (p = 0.006, ηp2 = 0.434), VO2 at first ventilatory threshold (p = 0.002, ηp2 = 0.520), velocity at second ventilatory threshold (p < 0.001, ηp2 = 0.997), VO2 at second ventilatory threshold (p < 0.001, ηp2 = 0.628), and peak velocity (p = 0.010, ηp2 = 0.386), and a decrease in respiratory exchange ratio (p < 0.001, ηp2 = 0.695).

Conclusions

Our findings suggest that although physiological and performance alterations were evident with Actovegin supplementation during cardiopulmonary exercise, no further benefits beyond those obtained with a placebo were attained.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Exercise TestOxygen ConsumptionAthletesHumansDouble-Blind MethodMaleYoung AdultFemaleAthletic PerformanceDietary SupplementsBlood PressureAdultHeart Rate

Stichwörter der Autor:innen

SolcoserylVO2maxaerobic capacityanti-dopingcalf bloodcardiorespiratory fitness

Autor:innen und Institutionen

  • Military Medical Academy, 11000 Belgrade, Serbia.
  • Faculty of Sport and Physical Education, University of Niš, 18000 Niš, Serbia.
  • Faculty of Medical Sciences, Department of Physiology, University of Kragujevac, 34000 Kragujevac, Serbia.
  • Department of Human Pathology, 1st Moscow State Medical University IM Sechenov, 119991 Moscow, Russia.
  • School of Health, Medical and Applied Sciences, Central Queensland University, Rockhampton 4701, Australia.
  • Faculty of Medicine, Department of Physiology, University of Banja Luka, 78101 Banja Luka, Bosnia and Herzegovina.

ORCID-Profile: Dragana Milovanović, Dragan Radovanović, Ivan Srejović, Vladimir Jakovljević, Aaron Scanlan, Emilija Stojanović

Förderung

  • Faculty of Medical Sciences
  • Ministry of Science, Technological Development, and Innovation of the Republic of Serbia
  • L’Oréal-UNESCO “For Women in Science” Serbian national programme and Humboldt Research Fellowship Programme for Experienced Researchers

Zitieren

APA

Milovanović, D., Radovanović, D., Živković, V., Srejović, I., Glišić, M., Jakovljević, V., Scanlan, A., Ponorac, N., & Stojanović, E. (2024). The Physiological and Performance Effects of Actovegin during Maximal Cardiopulmonary Exercise Testing: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. https://doi.org/10.3390/nu16193332

Vancouver

Milovanović D, Radovanović D, Živković V, Srejović I, Glišić M, Jakovljević V, et al. The Physiological and Performance Effects of Actovegin during Maximal Cardiopulmonary Exercise Testing: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2024. doi:10.3390/nu16193332

BibTeX
@article{Milovanovi2024,
  author = {Milovanović, Dragana and Radovanović, Dragan and Živković, Vladimir and Srejović, Ivan and Glišić, Miloš and Jakovljević, Vladimir and Scanlan, Aaron and Ponorac, Nenad and Stojanović, Emilija},
  title = {The Physiological and Performance Effects of Actovegin during Maximal Cardiopulmonary Exercise Testing: A Randomized, Double-Blind, Placebo-Controlled Trial},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16193332}
}
Kostenlos starten →